Company Filing History:
18 out of 63 
4 out of 4 
4 out of 4 
Years Active: 2005-2025
Title: Innovations and Contributions of Sergey Anatolievich Lukyanov
Introduction
Sergey Anatolievich Lukyanov is a prominent inventor based in Moscow, Russia, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 35 patents, Lukyanov has focused his research on developing monoclonal antibodies that address critical health issues related to the human T cell receptor family.
Latest Patents
Among his latest innovations are two noteworthy patents related to monoclonal antibodies against the beta chain region of human TRBV9. The first patent describes a monoclonal humanized antibody or its antigen-binding fragment that specifically targets the TRBV9 family of the human T cell receptor. This invention encompasses a nucleic acid encoding the antibody, an expression vector, a method for antibody preparation, and potential therapeutic uses for treating diseases connected to the human T cell receptor family. The applications of these antibodies specifically include conditions such as ankylosing spondylitis, celiac disease, and malignant blood diseases.
The second patent relates to monoclonal antibodies designed to inhibit the T cell receptor, also targeting the TRBV9 family. This invention includes a nucleic acid coding for the antibody or an antigen-binding fragment, an expression vector, and methodologies for producing the antibody. These innovations aim to eliminate T-cells carrying T-cell receptors of the TRBV9 family, making them instrumental in treating various blood cancers and autoimmune disorders.
Career Highlights
Lukyanov's career has been marked by his association with renowned organizations in the biotechnology sector. He has worked with Clontech Laboratories, Inc. and Evrogen IP Joint Stock Company, where he has applied his expertise to develop groundbreaking biotechnological solutions.
Collaborations
Throughout his career, Lukyanov has collaborated with esteemed colleagues, including Arcady Fedorovich Fradkov and Yulii Aleksandrovich Labas. These collaborations have facilitated the advancement of research and development in biotechnology, further enhancing his contributions to the field.
Conclusion
Sergey Anatolievich Lukyanov stands out as a significant figure in the realm of biotechnology with his innovative patents and collaborations. His dedicated work on monoclonal antibodies has the potential to transform treatments for various diseases, solidifying his reputation as a leading inventor in the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.